We report in the current study that JMJD6 is up-regulated in a variety of cancers, including melanoma, thyroid cancer, ovarian cancer, breast cancer, prostate cancer, lung adenocarcinomas, liver cancer, and colorectal cancer. Here, JMJD6 is linked to ovarian carcinoma.